Liver cancer incidence and death rates are increasing rapidly. Although there is no screening test for the disease, minimizing risk factors—hepatitis B and C, smoking, obesity and type 2 diabetes—could prevent many cases from developing.
by Sue Rochman
In a session at the AACR Annual Meeting, oncologists discussed the state of cancer precision medicine—and engaged with patient advocates.
Advocates shared their stories and projects at the AACR Annual Meeting.
National Cancer Institute director Norman “Ned” Sharpless meets with advocates and outlines areas of focus for the agency.
The Biden Cancer Initiative Colloquium gathered experts to discuss obstacles preventing access to care at the AACR Annual Meeting.
To increase efficacy and combat resistance to checkpoint inhibitors, many clinical trials are centered on combining an immune checkpoint inhibitor with a second drug.
The FDA expands use of durvalumab to non–small cell lung cancer.
A collaborative initiative seeks to improve understanding of cancer outcomes in African-American patients through genomic sequencing.
The Financial Toll of Cancer
donate to the AACR
The AACR Cancer Progress Report 2017, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.